Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

LEADER ENVIRONMENTAL TECHNOLOGIES LIMITED (LS9)

  • SEC News
  • April 13, 2026, 10:09 UTC
  • 0
  • 0 comments

General Announcement: CHANGES IN THE COMPOSITION OF THE BOARD OF DIRECTORS AND BOARD COMMITTEES

Comment Full text

VINS HOLDINGS LTD (VIN)

  • SEC News
  • April 13, 2026, 10:08 UTC
  • 0
  • 0 comments

Annual Reports and Related Documents:

Comment Full text

TSH RESOURCES BERHAD (TSH)

  • SEC News
  • April 13, 2026, 10:08 UTC
  • 0
  • 0 comments

General Announcement: Monthly Production Figures & Disclosure on Quarterly Production- March 2026

Comment Full text

VINS HOLDINGS LTD (VIN)

  • SEC News
  • April 13, 2026, 10:08 UTC
  • 0
  • 0 comments

Annual General Meeting :

Comment Full text

LEADER ENVIRONMENTAL TECHNOLOGIES LIMITED (LS9)

  • SEC News
  • April 13, 2026, 10:07 UTC
  • 0
  • 0 comments

Change - Announcement of Cessation: Retirement of Dr Ng Wun Jern as Independent Non-Executive Director

Comment Full text

ASE TECHNOLOGY HOLDING CO., LTD. (ASX)

  • SEC News
  • April 13, 2026, 10:06 UTC
  • 0
  • 1 comments

Director Chang Chien Shen 🟡 adjusted position in 0 shares (2 derivative) of ASE Technology Holding Co., Ltd. (ASX) at $99.70 ($545.7M) Transaction Date: Apr 09, 2026 | Filing ID: 005636

Comment Full text

IDEAYA BIOSCIENCES, INC. (IDYA)

  • SEC News
  • April 13, 2026, 10:05 UTC
  • 0
  • 1 comments

(90% Positive) IDEAYA BIOSCIENCES, INC. (IDYA) Announces Clinical Development Update

Comment Full text

ASPIAL CORPORATION LIMITED (A30)

  • SEC News
  • April 13, 2026, 10:03 UTC
  • 0
  • 0 comments

Annual Reports and Related Documents:

Comment Full text

ASPIAL CORPORATION LIMITED (A30)

  • SEC News
  • April 13, 2026, 10:02 UTC
  • 0
  • 0 comments

Annual General Meeting :

Comment Full text

LEADER ENVIRONMENTAL TECHNOLOGIES LIMITED (LS9)

  • SEC News
  • April 13, 2026, 10:01 UTC
  • 0
  • 0 comments

Financial Statements and Related Announcement: Discrepancies between unaudited and audited accounts

Comment Full text
  • Previous
  • 722
  • 723
  • 724
  • 725
  • 726
  • Next

Search

News categories

  • Technical Exchange News(11899)
  • Event(4741)
  • SEC News(243356)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(146868)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin